Add this topic to your myFT Digest for news straight to your inbox
You select the topic, we deliver the news.
Sample the FT’s top stories for a week
Invalid email
By signing up you confirm that you have read and agree to the terms and conditions, cookie policy and privacy policy.
Mark Moore to join Uber’s Elevate division after 30 years at US space agency
How a shrinking Everest and heavier kilogramme change our view of the world
Group reports big profit rise for 2016 partly due to gains on asset disposals
Experts call for urgent action to fight drug-resistant parasites in Southeast Asia
Scientists say machine could solve problems beyond conventional electronics
Winners developed technology used in all today’s digital cameras and smartphones
Using natural gas to create nutrition for fish and pigs benefits a hungry world
The risk is ageing platforms are seen as tech rather than business concerns
There is real tension between policies on climate change and pollution
Industry executives welcome president’s vow as way to lower prices
Texas Hold ’em tournament set men against AI program
Collaboration with Novo Nordisk part of strategy to revive UK drug discovery research
First reported success from research that aims to grow human tissue in large animals
Questions asked about price paid for Swiss group and spin-off of promising new drugs
Deal has the untidy look that can result from late concessions
Danish drugmaker hails neuroscience breakthrough in breaching the blood-brain barrier
A wave of disruption looms for the country’s flagship industries — cars and machines — from Silicon Valley innovation
More than one-third of differences between individuals down to genetics, study finds
Acrylamide formed by cooking starchy foods for long periods at high temperatures
The technology entrepreneur talks about challenging bureaucracy
Leader is to set out industrial policy focusing on ‘critical national infrastructure’
Silicon Valley fears vilification like bankers for prospering at expense of everyman
Billion-dollar programme aims to cut vaccine-development time from 12 years to one